Association analysis of myosin IXB and type 1 diabetes

Human Immunology

Volumn 71, Issue 6, 2010, Pages 598-601

  Persengiev, Stephan ^a,b   Koeleman, Bobby P C ^a,b   Downes, Kate ^c   Valdigem, Gustavo ^b   van der Slik, Arno R ^a   Eerligh, Peter ^a   Monsuur, Alienke ^b   Bruining, G Jan ^d   Wijmenga, Cisca ^e   Todd, John A ^c   Roep, Bart O ^a   Alizadeh, Behrooz Z ^a,b,e  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^e UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Celiac disease; Diabetes; Genetics; Immunity; Intestinal permeability; MYO9B

Indexed keywords

MYOSIN; MYOSIN IXB; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; CHILD; CONTROLLED STUDY; ENTERITIS; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENOTYPE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; JUVENILE DIABETES MELLITUS; MAJOR CLINICAL STUDY; NETHERLANDS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; UNITED KINGDOM; CASE CONTROL STUDY; COMPARATIVE STUDY; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; INFANT; METABOLISM; NUCLEOTIDE SEQUENCE; PRESCHOOL CHILD;

ADOLESCENT; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DENMARK; DIABETES MELLITUS, TYPE 1; DNA MUTATIONAL ANALYSIS; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GREAT BRITAIN; HUMANS; INFANT; MYOSINS; POLYMORPHISM, SINGLE NUCLEOTIDE; NETHERLANDS;

EID: 77952885961     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2010.03.002     Document Type: Article

References (27)

1. Concannon P., Erlich H.A., Julier C., Morahan G., Nerup J., Pociot F., et al. Type 1 diabetes: Evidence for susceptibility loci from four genome-wide linkage scans in 1,435 multiplex families. Diabetes 2005, 54:2995-3001.
2. Monsuur A.J., Bakker P.I., Alizadeh B.Z., Zhernakova A., Bevova M.R., Strengman E., et al. Myosin IXB variant increases the risk of celiac disease and points toward a primary intestinal barrier defect. Nat Genet 2005, 37:1341-1344.
3. Smyth D.J., Plagnol V., Walker N.M., Cooper J.D., Downes K., Yang J.H., et al. Shared and distinct genetic variants in type 1 diabetes and celiac disease. N Engl J Med 2008, 359:2767-2777.
4. Hunt K.A., Monsuur A.J., McArdle W.A., et al. Lack of association of MYO9B genetic variants with coeliac disease in a British cohort. Gut 2006, 55:969-972.
5. Cirillo G., Di Domenico M.R., Corsi I., Gagliardo T., Del Giudice E.M., Perrone L., et al. Do MYO9B genetic variants predispose to coeliac disease?. An association study in a cohort of South Italian children. Dig Liver Dis 2007, 39:228-231.
6. van Bodegraven A.A., Curley C.R., Hunt K.A., Monsuur A.J., et al. Genetic variation in myosin IXB is associated with ulcerative colitis. Gastroenterology 2006, 131:1768-1774. K, LR.
7. Cooney R., Cummings J.R., Pathan S., Beckly J., Geremia A., Hancock L., et al. Association between genetic variants in myosin IXB and Crohn's disease. Inflamm Bowel Dis 2009, 15:1014-1021.
8. Amundsen S.S., Vatn M., Wijmenga C., Sollid L.M., Lie B.A., et al. Association analysis of MYO9B gene polymorphisms and inflammatory bowel disease in a Norwegian cohort. Tissue Antigens 2006, 6:249-252.
9. Vaarala O., Atkinson M.A., Neu J. The "perfect storm" for type 1 diabetes: The complex interplay between intestinal microbiota, gut permeability, and mucosal immunity. Diabetes 2008, 57:2555-2562.
10. Neu J., Reverte C.M., Mackey A.D., Liboni K., Tuhacek-Tenace L.M., Hatch M., et al. Changes in intestinal morphology and permeability in the biobreeding rat before the onset of type 1 diabetes. J Pediatr Gastroenterol Nutr 2005, 40:589-595.
11. Maurano F., Mazzarella G., Luongo D., Stefanile L., D'Arienzo R., Rossi M., et al. Small intestinal enteropathy in non-obese diabetic mice fed a diet containing wheat. Diabetologia 2005, 48:931-937.
12. Carratu R., Secondulfo M., de Magistris L., Iafusco D., Urio A., Carbone M.G., et al. Altered intestinal permeability to mannitol in diabetes mellitus type I. J Pediatr Gastroenterol Nutr 1999, 28:264-269.
13. Mooradian A.D., Morley J.E., Levine A.S., Prigge W.F., Gebhard R.L. Abnormal intestinal permeability to sugars in diabetes mellitus. Diabetologia 1986, 29:221-224.
14. Meddings J.B., Jarand J., Urbanski S.J., Hardin J., Gall D.G. Increased gastrointestinal permeability is an early lesion in the spontaneously diabetic BB rat. Am J Physiol 1999, 276:951-957.
15. Vaarala O. Intestinal immunity and type 1 diabetes. J Pediatr Gastroenterol Nutr 2004, 39:732-733.
16. Paronen J., Klemetti P., Kantele J.M., Savilahti E., Perheentupa J., Akerblom H.K., et al. Glutamate decarboxylase-reactive peripheral blood lymphocytes from patients with IDDM express gut-specific homing receptor alpha4beta7-integrin. Diabetes 1997, 46:583-588.
17. Vaarala O., Klemetti P., Savilahti E., Reijonen H., Ilonen J., Akerblom H.K. Cellular immune response to cow's milk beta-lactoglobulin in patients with newly diagnosed IDDM. Diabetes 1996, 45:178-182.
18. Hanninen A., Taylor C., Streeter P.R., Stark L.S., Sarte J.M., Shizuru J.A., et al. Vascular addressins are induced on islet vessels during insulitis in nonobese diabetic mice and are involved in lymphoid cell binding to islet endothelium. J Clin Invest 1993, 92:2509-2515.
19. Santiago J.L., Martinez A., Nunez C., de la Calle H., Fernandez-Arquero M., de la Concha E.G., et al. Association of MYO9B haplotype with type 1 diabetes. Hum Immunol 2008, 69:112-115.
20. Alizadeh B.Z., Eerligh P., van der Slik A.R., Shastry A., Zhernakova A., Valdigem G., et al. Mica marks additional risk factors for type 1 diabetes on extended HLA haplotypes: An association and meta-analysis. Mol Immunol 2007, 44:2806-2812.
21. Amundsen S.S., Monsuur A.J., Wapenaar M.C., Lie B.A., Ek J., Gudjónsdóttir A.H., et al. Association analysis of MYO9B gene polymorphisms with celiac disease in a Swedish/Norwegian cohort. Hum Immunol 2006, 67:341-345.
22. Giordano M., Marano C., Mellai M., Limongelli M.G., Bolognesi E., Clerget-Darpoux F., et al. A family-based study does not confirm the association of MYO9B with celiac disease in the Italian population. Genes Immun 2006, 7:606-608.
23. Nunez C., Marquez A., Varade J., Martinez A., Polanco I., Maluenda C., et al. No evidence of association of the MYO9B polymorphisms with celiac disease in the Spanish population. Tissue Antigens 2006, 68:489-492.
24. Tenesa A., Dunlop M.G. Validity of tagging SNPs across populations for association studies. Eur J Hum Genet 2006, 14:357-363.
25. Mueller J.C., Lohmussaar E., Magi R., Remm M., Bettecken T., Lichtner P., et al. Linkage disequilibrium patterns and tagSNP transferability among European populations. Am J Hum Genet 2005, 76:387-398.
26. Arnott I.D., Nimmo E.R., Drummond H.E., Fennell J., Smith B.R., MacKinlay E., et al. NOD2/CARD15, TLR4 and CD14 mutations in Scottish and Irish Crohn's disease patients: Evidence for genetic heterogeneity within Europe?. Genes Immun 2004, 5:417-425.
27. Cavanaugh J. NOD2: Ethnic and geographic differences. World J Gastroenterol 2006, 12:3673-3677.